Greater haemodialysis exposure ('quotidian haemodialysis') has different mortality associations by patient age group.

Although quotidian HD conferred survival benefit in crude analyses, people ≥75 years of age had greater mortality with quotidian HD than standard HD. The mortality benefit in younger people was attenuated when adjusted for known confounders.